{"disease":{"id":"autoimmune-haemolytic-anaemia","name":"autoimmune haemolytic anaemia"},"drugs":{"marketed":[{"drug_id":"azathioprine","indication_name":"Refractory autoimmune haemolytic anaemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Imuran","generic_name":"AZATHIOPRINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Purine Antimetabolite [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04070612","title":"National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07086976","title":"A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06534021","title":"IASO-782 in Autoimmune Hematological Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Shanghai IASO Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT04269551","title":"A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Bioverativ, a Sanofi company","has_results":false},{"nct_id":"NCT04802057","title":"Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Bioverativ, a Sanofi company","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}